SNORA21 and SNORA42 are negatively correlated with the survival rate of CRC patients; overexpression of them promotes proliferation, migration, and invasion of CRC cells and also enhances tumorigenicity [9, 10]. Here, SNORA21 is linked to colorectal carcinoma.